Pulmonary arterial hypertension: a rare disease that encourages the development of multiple treatments
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pulmonary arterial hypertension: a rare disease that encourages the development of multiple treatments
Authors
Keywords
-
Journal
Expert Opinion on Orphan Drugs
Volume 2, Issue 11, Pages 1137-1145
Publisher
Informa Healthcare
Online
2014-05-29
DOI
10.1517/21678707.2014.924851
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selexipag for the treatment of pulmonary arterial hypertension
- (2014) Nika Skoro-Sajer et al. EXPERT OPINION ON PHARMACOTHERAPY
- Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients
- (2014) Gérald Simonneau et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Coughing up Urine: Urinoptysis?
- (2013) Dipen Kadaria et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension
- (2013) Marius M. Hoeper et al. CIRCULATION
- Pathology of Pulmonary Hypertension
- (2013) Rubin M. Tuder et al. CLINICS IN CHEST MEDICINE
- Oral Therapies for Pulmonary Arterial Hypertension
- (2013) Richard Channick et al. CLINICS IN CHEST MEDICINE
- Parenteral and Inhaled Prostanoid Therapy in the Treatment of Pulmonary Arterial Hypertension
- (2013) Vallerie V. McLaughlin et al. CLINICS IN CHEST MEDICINE
- Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertension
- (2013) Jasper Dingemanse et al. Expert Opinion On Drug Safety
- Combination therapy in the management of pulmonary arterial hypertension
- (2013) M. S. Buckley et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Updated Treatment Algorithm of Pulmonary Arterial Hypertension
- (2013) Nazzareno Galiè et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pulmonary Arterial Hypertension
- (2013) Michael D. McGoon et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- P66
- (2013) Ed L. Parsley et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Orphan drug approvals in Europe since 2001: an analysis by indication
- (2013) Peter Norman Expert Opinion on Orphan Drugs
- Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study)
- (2012) Victor F. Tapson et al. CHEST
- Long-Term Hepatic Safety of Ambrisentan in Patients With Pulmonary Arterial Hypertension
- (2012) Ori Ben-Yehuda et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inhaled treprostinil: a therapeutic review
- (2012) Richard Channick et al. Drug Design Development and Therapy
- Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension
- (2012) Dioma U. Udeoji et al. Therapeutic Advances in Respiratory Disease
- Role of the endogenous elastase inhibitor, elafin, in cardiovascular injury
- (2011) Shirjel R. Alam et al. BIOCHEMICAL PHARMACOLOGY
- Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States
- (2011) Noam Y. Kirson et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Angiotensin-Converting Enzyme 2/Angiogenesis-(1–7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension
- (2010) Vinayak Shenoy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States
- (2010) Adaani E. Frost et al. CHEST
- The Dichloroacetate Dilemma: Environmental Hazard versus Therapeutic Goldmine—Both or Neither?
- (2010) Peter W. Stacpoole ENVIRONMENTAL HEALTH PERSPECTIVES
- Estrogens and Development of Pulmonary Hypertension: Interaction of Estradiol Metabolism and Pulmonary Vascular Disease
- (2010) Stevan P Tofovic JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
- (2009) et al. CIRCULATION
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
- (2009) et al. EUROPEAN HEART JOURNAL
- Tadalafil for the treatment of pulmonary arterial hypertension
- (2009) Erika B Rosenzweig EXPERT OPINION ON PHARMACOTHERAPY
- Effects of Long-Acting Beraprost Sodium (TRK-100STP) in Japanese Patients With Pulmonary Arterial Hypertension
- (2009) Takeyoshi Kunieda et al. International Heart Journal
- Updated Clinical Classification of Pulmonary Hypertension
- (2009) Gérald Simonneau et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cicletanine for the Treatment of Pulmonary Arterial Hypertension
- (2008) Aaron B. Waxman et al. ARCHIVES OF INTERNAL MEDICINE
- Ambrisentan
- (2008) Jamie D Croxtall et al. DRUGS
- Prostacyclin therapies for the treatment of pulmonary arterial hypertension
- (2008) M. Gomberg-Maitland et al. EUROPEAN RESPIRATORY JOURNAL
- Inhalation of vasoactive intestinal peptide in pulmonary hypertension
- (2008) H. H. Leuchte et al. EUROPEAN RESPIRATORY JOURNAL
- Endothelin receptor antagonists in pulmonary arterial hypertension
- (2008) J. Dupuis et al. EUROPEAN RESPIRATORY JOURNAL
- Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist
- (2008) M. Iglarz et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started